Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes

AIMS

To evaluate oncological and renal function outcomes of stereotactic body radiotherapy (SBRT) for medically inoperable patients with localised renal cell carcinoma.

MATERIALS AND METHODS

Consecutive patients treated with curative intent SBRT (30-45 Gy in five fractions or 42 Gy in three fractions) were included. Data on local control (Response Evaluation Criteria in Solid Tumors [RECIST] v1.1), distant metastasis, impact on estimated glomerular filtration rate (eGFR) and proportional ipsilateral and contralateral renal functions (measured through renal scans) were collected. Univariate and multivariable analyses were conducted to determine association of variables with oncological and renal function outcomes.

RESULTS

Seventy-four patients were analysed. The median follow-up was 27.8 months (interquartile range 17.6-41.7). Fifty-seven per cent had tumours ≥ T1b. One-, 2- and 4-year cumulative incidence of local failure was 5.85, 7.77 and 7.77%, respectively. The cumulative incidence of distant metastasis at 2 years was 4.24%. On multivariable analysis, a lower planning target volume (PTV) mean dose (P = 0.019) and a larger PTV (P = 0.005) were significantly associated with the risk of developing local failure. A lower PTV maximum dose (P = 0.039) was significantly associated with the risk of developing distant metastasis. The median change in global eGFR (ml/min) from pre-SBRT levels was -7.0 (interquartile range -14.5 to -1.0) at 1 year and -11.5 (interquartile range -19.5 to -4.0) at 2 years. The proportion of ipsilateral (differential) renal function decreased over time from 47% of overall renal function pre-SBRT to 36% at 2 years, whereas the proportion of contralateral renal function correspondingly improved. On multivariable analysis, a higher volume of uninvolved renal cortex (P < 0.0001) was significantly associated with a smaller decrease in eGFR over time.

CONCLUSION

In this large institutional cohort, oncological outcomes of renal cell carcinoma treated with SBRT were favourable and a longitudinal decline in renal function in the ipsilateral kidney and compensatory increase in the contralateral kidney were observed. Clinical and dosimetric factors were significantly associated with oncological and renal function outcomes.

Post-fire redistribution of 137Cs and algal communities in contaminated forest soils in Belarus

This study was carried out in the forest area of the Gomel region of Belarus contaminated by ¹³⁷Cs following the Chernobyl accident of 1986. The aim of the study was to explore the effects of different types of wildfires on the biological availability of radionuclides and the distribution of algal communities in fire-affected soils. Soil samples were collected in 2017 and 2018 from sites burnt by surface and crown fires, and from two unburnt reference locations. The soil samples were analyzed for radioactivity, agrochemical characteristics and the abundance of photoautotrophs. The proportions of various ¹³⁷Cs fractions, according to our findings, differ between fire-affected and unburnt forest soils, and also between the different types of wildfire. The forest soil affected by surface fire is characterized by an increased amount of easily exchangeable and mobile fractions. In the forest burnt by the crown fire, where the above ground vegetation was almost completely destroyed, the mobile fractions of ¹³⁷Cs are easily washed out from the topsoil, allowing them to penetrate into deeper soil layers. Soil algae play an important ecological role in sustaining terrestrial ecosystems and are sensitive to various physicochemical properties of soil, such as pH level, nutrient content and moisture. Most of these physicochemical properties are known to stimulate the growth of algal cells, however no evidence has been found in this study regarding the relationship between ¹³⁷Cs activities in soil and the algal species richness.

Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials

AIMS

We conducted a pooled analysis of four prospective stereotactic body radiotherapy (SBRT) trials of low- and intermediate-risk prostate cancer to evaluate the incidence of prostate-specific antigen (PSA) bounce and its correlation with the time-dose-fraction schedule. The correlation between bounce with PSA response at 4 years (nadir PSA < 0.4 ng/ml) and biochemical failure-free survival (BFFS) was also explored.

MATERIALS AND METHODS

The study included four treatment groups: 35 Gy/five fractions once per week (QW) (TG-1; n = 84); 40 Gy/five fractions QW (TG-2; n = 100); 40 Gy/five fractions every other day (TG-3; n = 73); and 26 Gy/two fractions QW (TG-4; n = 30). PSA bounce was defined as a rise in PSA by 0.2 ng/ml (nadir + 0.2) or 2 ng/ml (nadir + 2.0) above nadir followed by a decrease back to nadir. Patients with fewer than three follow-up PSA tests were excluded from the pooled analysis.

RESULTS

In total, 287 patients were included, with a median follow-up of 5.0 years. The pooled 5-year cumulative incidence of bounce by nadir + 2.0 was 8%. The 2-year cumulative incidences of PSA bounce by nadir + 0.2 were 28.9, 21, 19.6 and 16.7% (P = 0.12) and by nadir + 2.0 were 7.2, 8, 2.7 and 6.7% (P = 0.32) for TG-1 to TG-4, respectively. Multivariable analysis revealed that for nadir + 2.0, pre-treatment PSA (odds ratio 0.49; 95% confidence interval 0.26-0.97) correlated with PSA bounce. Although PSA bounce by nadir + 0.2 (odds ratio 0.10; 95% confidence interval 0.04-0.24) and nadir + 2.0 (odds ratio 0.29; 95% confidence interval 0.09-0.93) was associated with a lower probability of PSA response at 4 years, there was no association between bounce by nadir + 0.2 (hazard ratio 0.36; 95% confidence interval 0.08-1.74) or nadir + 2 (hazard ratio 1.77; 95% confidence interval 0.28-11.07) with BFFS.

CONCLUSION

The incidence of PSA bounce was independent of time-dose-fraction schedule for prostate SBRT. One in 13 patients experienced a bounce high enough to be misinterpreted as biochemical failure, and clinicians should avoid early salvage interventions in these patients. There was no association between PSA bounce and BFFS.

Sci-Fri PM: Delivery - 03: Spine SBRT: Treating multiple vertebrae using cone-beam CT image-guidance and the hexapod robotic couch

PURPOSE

The intent of spinal SBRT is to maximize the biological effective dose and improve local control, while sparing the adjacent spinal cord. We report on the spinal SBRT positional accuracy for multiple, consecutive vertebrae in a single course, using the Elekta Synergy-S and BodyFIX immobilization systems.

METHODS

After initial patient adjustment, verification cone-beam CT (CBCT) images were acquired before, during and after treatment. These images were used to assess immobilization and correct any misalignment exceeding 1 mm or 1°, in all six degrees-of-freedom using the HexaPOD robotic couch. This analysis is based on 415 verification images from 67 consecutive courses of treatment. These treatment courses comprised 25 single thoracic vertebrae, 16 multiple thoracic vertebrae, 20 single lumbar vertebrae and 6 multiple lumbar vertebrae.

RESULTS

The absolute intra-fraction motion averaged over all directions (±std dev.) for the T-single, T-multiple, L-Single and L-Multiple was 0.54 (±0.73) mm, 0.54 (±0.88) mm, 0.36 (±0.57) mm, and 0.47 (±0.63) mm respectively. The percentage that exceeded the 1.5 mm planning margin was 3.8%, 4.0%, 1.0% and 0.85% respectively. T-spine treatments were out-of-tolerance more frequently than the L-spine. There was a statistically significant difference between single and multiple lumbar treatments (unpaired t-test, p<0.01), but this was not clinically significant as 99% were within our 1.5 mm margin.

CONCLUSIONS

Near-rigid immobilization with the acquisition of intra-fraction CBCT images and the correction of misalignments in all six degrees-of-freedom provides the necessary precision to safely perform SBRT of consecutive spinal metastases within one course of treatment.